T1	HMM 879 1002	values for plasma amprenavir (APV) area under the concentration-time profile over the dosing interval (tau) at steady state
T2	HMM 1017 1134	maximum concentration of drug in plasma (C(max)), and plasma concentration at the end of tau at steady state (C(tau))
T3	HMM 1186 1238	values for plasma RTV AUC(0-tau), C(max), and C(tau)
T4	HMM 1394 1446	values for plasma APV AUC(0-tau), C(max), and C(tau)
T5	HMM 1509 1550	plasma RTV AUC(0-tau), C(max), and C(tau)
T6	HMM 1746 1792	rate of marked hepatic transaminase elevations
T7	HMM 1797 1831	lack of pharmacokinetic advantage.
